2015
DOI: 10.15254/h.j.d.med.7.2015.151
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: ABSTRACT

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Many new direct oral anticoagulants have been developed, but they are not widely used in India owing to high costs, lack of specific laboratory monitoring tests, unavailability of specific antidotes, and serious bleeding in patients with renal impairment. 4 As the therapeutic ranges of warfarin and acenocoumarol are narrow and affected by many factors such as diet-drug and drug-drug interactions, their use is challenging. 5 In a study from Saudi Arabia, only 31.8% (95/298) of the enrolled patients were reported to adhere to the therapy.…”
mentioning
confidence: 99%
“…Many new direct oral anticoagulants have been developed, but they are not widely used in India owing to high costs, lack of specific laboratory monitoring tests, unavailability of specific antidotes, and serious bleeding in patients with renal impairment. 4 As the therapeutic ranges of warfarin and acenocoumarol are narrow and affected by many factors such as diet-drug and drug-drug interactions, their use is challenging. 5 In a study from Saudi Arabia, only 31.8% (95/298) of the enrolled patients were reported to adhere to the therapy.…”
mentioning
confidence: 99%